Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06202339 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 31, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva.
Trial Details
NCT Number NCT06202339
Lead Sponsor Alpha Tau Medical LTD.
Conditions
(from sponsor)		 Carcinoma of the Vulva, Recurrent Carcinoma of the Vulva
Related terms Neoplasms, Vulvar Neoplasms
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov